The Development Center for Biotechnology (DCB) was established as a nonprofit research institution in 1984 using funds provided by the public and private sectors. Currently located in the National Biotechnology Research Park, the DCB champions technological innovation, industrial development, and talent cultivation as its core values. We focus on preclinical development and translational medicine research, and play a vital role in drug commercialization to drive the development of the biotechnology industry in Taiwan.
The DCB focuses on research and development (R&D) of novel drugs and treatment. We offer technology licensing services as well as integration services from commissioned research to business promotion, in addition to fostering international collaborations. Besides, the DCB aims to become the “best partner” in the biotechnology industry. Through innovative R&D, business incubation, and business promotion, we utilize our cumulative capacity in drug R&D to align with international biotechnology and pharmaceutical development trends, thereby ensuring the quality of life and health of Taiwanese people.
Mission
- Focus on the preclinical development of biologics and small-molecule drugs for alignment with the National Biotechnology Research Park’s research position on translational medicine.
- Develop the platform technology for drug optimization to connect with upstream target identification for new drug value adding.
- Form a cluster by connecting the Academia Sinica and biotech companies in the park to accelerate new drug development and commercialization.